Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

133
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
133
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

250
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
250
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

653
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
653
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

198
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
198
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

239
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
239
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

151
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
151

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel Approach to the Design and Sample Size Planning of Animal Experiments Based on Effect Estimation.

Biometrical journal. Biometrische Zeitschrift·2026
Same author

Integration of Real-World Data into Clinical Trials: An Interdisciplinary Discussion from Regulatory and Practical Perspectives.

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2026
Same author

Design Considerations for a Phase II Platform Trial in Major Depressive Disorder.

Pharmaceutical statistics·2025
Same author

Precemtabart tocentecan, an anti-CEACAM5 antibody-drug conjugate, in metastatic colorectal cancer: a phase 1 trial.

Nature medicine·2025
Same author

Estimation of treatment effects in early phase randomized clinical trials involving multiple data sources for external control.

Journal of biopharmaceutical statistics·2025
Same author

Six solutions for clinical study data sharing in Germany.

BMC medical research methodology·2025

Related Experiment Video

Updated: Jan 8, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.4K

Informing the Borrowing Process for Dose-Finding Trials by Estimating the Similarity Between Population-Specific

Dario Zocholl1, Heiko Götte2, Christina Habermehl2

  • 1Institute for Medical Biometry, Informatics and Epidemiology, Faculty of Medicine, University of Bonn, Bonn, Germany.

Pharmaceutical Statistics
|December 19, 2025
PubMed
Summary

This study introduces a novel method for pediatric dose-finding trials, empirically determining data borrowing from adult trials. This approach enhances precision in small populations by analyzing compound similarity, improving Bayesian methods.

Keywords:
Bayesian borrowingdose‐findingmeta‐analysispediatric

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.6K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.5K

Related Experiment Videos

Last Updated: Jan 8, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.4K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.6K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.5K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacometrics

Background:

  • Dose-finding trials in small populations, like pediatrics, present significant challenges.
  • Current Bayesian methods borrow information from adult trials but the extent of borrowing is subjective.
  • Existing methods lack objective criteria for determining the optimal degree of data borrowing.

Purpose of the Study:

  • To propose an empirical approach for determining the degree of information borrowing in dose-finding trials.
  • To apply this approach to pediatric dose-finding, leveraging meta-analysis of similar compounds.
  • To evaluate the performance of different statistical models in conjunction with the proposed borrowing method.

Main Methods:

  • A meta-analysis of dose-toxicity curves from biologically similar compounds was conducted.
  • Two statistical modeling approaches, ExNex and hierarchical models, were applied.
  • The degree of similarity was translated into variance inflation or robust mixture prior distributions.

Main Results:

  • Mixture priors showed promising results, especially with a larger number of compounds (20).
  • Variance inflation models required further tuning and demonstrated less robustness.
  • With fewer compounds (3 or 7), the proposed methods performed comparably or slightly better than robust priors ignoring external data.

Conclusions:

  • The proposed empirical approach offers a data-driven method for optimizing information borrowing in dose-finding trials.
  • Mixture priors are particularly effective when external data from multiple similar compounds are available.
  • The practical adoption of this method may depend on the resources required to obtain external compound data.